Myeloma Trialists' Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials. J Clin Oncol 1998; 16: 3832-42.
Harousseau JL, Attal M, Divine M, et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French Registry on autologous transplantation in multiple myeloma. Blood 1995; 85: 3077-85.
Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autolugous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe francais du myélome. N Engl J Med 1996; 335: 91-7.
Bjorkstrand BB, Ljungman P, Svensson H, et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European group for blood and marrow transplantation. Blood 1996; 88: 4711-8.
Fife K, Howard MR, Gracie F, Phillips RH, Bower M. Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre. Int J STD AIDS 1998; 9: 751-5.
Kotoh T, Dhar DK, Masunagi R, et al. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice. Surgery 1999; 125: 536-44.
Soler RA, Howard M, Brink NS, Gibb D, Tedder RS, Nadal D. Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide. Clin Infect Dis 1996; 23: 501-3.
Verheul HM, Panigrahy D, Yuan J, D'Amato RJ. Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits. Br J Cancer 1999; 79: 114-8.
Munshi N, Wilson CS, Penn J, et al. Angiogenisis in newly diagnosed multiple myeloma: Poor prognosis with increased microvessel density (MVD) in bone marrow biopsies. Blood 1998; 92 (Suppl. 1): 98a.
D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994; 91: 4082-5.
Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999; 341: 1565-71.
Raje N, Anderson K. Thalidomide-a revival story. N Engl J Med 1999; 341: 1606-9.
Munshi N, Desikan KR, Anaissie E, et al. Peripheral blood stem cell collection (PBSC) after CAD + G-CSF as part of total therapy II in newly diagnosed multiple myeloma (MM): Influence of thalidomide (thal) administration. Blood 1999; 94 (Suppl. I) : 578a.